Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients.
| Autor: | Zamorano, L.1, Juan, C.1, Fernández-Olmos, A.2, Ge, Y.3, Cantón, R.2, Oliver, A.1 antonio.oliver@ssib.es |
|---|---|
| Zdroj: | Clinical Microbiology & Infection. Sep2010, Vol. 16 Issue 9, p1482-1487. 6p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|